These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE]. KLINGER R; DALLECOSTE P Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829 [No Abstract] [Full Text] [Related]
5. HYPOGLYCEMIC COMA DURING SULFONYLUREA THERAPY. BERGMAN H Acta Med Scand; 1965 Mar; 177():287-98. PubMed ID: 14281786 [No Abstract] [Full Text] [Related]
6. [Clinical indications and contraindications for peroral therapy of diabetics with sulfonylurea preparations]. STRAUZENBERG SE; HALLER H Z Gesamte Inn Med; 1959 Jun; 14():529-33. PubMed ID: 13835158 [No Abstract] [Full Text] [Related]
7. [ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS]. ROBBERS H; BRUMBY KH; TRAUMANN KJ Arzneimittelforschung; 1964 May; 14():406-9. PubMed ID: 14238600 [No Abstract] [Full Text] [Related]
9. [CLINICAL TRIALS OF ACETOHEXAMIDE, A NEW ORAL ANTIDIABETIC]. FIORIO C Minerva Med; 1964 Feb; 55():652-5. PubMed ID: 14161168 [No Abstract] [Full Text] [Related]
10. [SULFONYLUREA SENSITIVITY: ITS SIGNIFICANCE IN THE THERAPY AND PROGNOSIS OF DIABETES MELLITUS]. ANDREEV D Munch Med Wochenschr; 1964 Dec; 106():2259-62. PubMed ID: 14341467 [No Abstract] [Full Text] [Related]
11. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE]. CHANIS RA Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953 [No Abstract] [Full Text] [Related]
12. [CLINICAL TRIALS OF A BIGUANIDE-TOLBUTAMIDE COMBINATION]. TEITELBAUM M; MILLER G; VAGUE J Diabete; 1965 Jan; 13():25-31. PubMed ID: 14284496 [No Abstract] [Full Text] [Related]
13. RELATIONSHIP BETWEEN INTRAVENOUS GLUCOSE TOLERANCE AND THE FASTING BLOOD GLUCOSE LEVEL IN HEALTHY AND IN DIABETIC SUBJECTS. MOORHOUSE JA; GRAHAME GR; ROSEN NJ J Clin Endocrinol Metab; 1964 Feb; 24():145-59. PubMed ID: 14123838 [No Abstract] [Full Text] [Related]
14. [PROBLEMS OF LATE FAILURE OF ORAL SULFONYLUREA THERAPY OF DIABETES]. STRAUZENBERG SE; HALLER H; MEYER H Schweiz Med Wochenschr; 1965 May; 95():628-36. PubMed ID: 14305109 [No Abstract] [Full Text] [Related]
15. [CLINICAL EVALUATION OF A NEW HYPOGLYCEMIC AGENT WITH CHOLESTEROLEMIC ACTION (TOLAZAMIDE). PRELIMINARY REPORT]. ROJAS L; COLINABRACHO L; DOMENGE L Rev Invest Clin; 1964; 16():173-82. PubMed ID: 14170236 [No Abstract] [Full Text] [Related]
16. Clinical trial of amino-methylbenzol-sulphonyl-cyclohexylurea (metahexamide) in diabetics after failure of tolbutamide. HUSKISSON ID; JACKSON WP S Afr Med J; 1960 Jan; 34():34-5. PubMed ID: 14405589 [No Abstract] [Full Text] [Related]
17. CLINICAL STUDY OF TOLAZAMIDE: A NEW ANTIDIABETIC SULFONYLUREA. STERN SB J La State Med Soc; 1965 Jun; 117():198-202. PubMed ID: 14292548 [No Abstract] [Full Text] [Related]
18. ACETOHEXAMIDE ('DIMELOR') IN DIABETES. HERMAN M; JACKSON WP S Afr Med J; 1964 Jul; 38():519-22. PubMed ID: 14182168 [No Abstract] [Full Text] [Related]
19. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics]. Vailati G; Montini M; Pagani G; Caputo G Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667 [No Abstract] [Full Text] [Related]
20. [REPORT ON THE CLINICAL TESTING OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC]. LEUBNER H Arzneimittelforschung; 1964 May; 14():404-6. PubMed ID: 14238599 [No Abstract] [Full Text] [Related] [Next] [New Search]